Background <p>Panhypopituitarism is a rare endocrine disorder characterized by deficiency of multiple pituitary hormones. Because prolactin and oxytocin are essential for lactation, breastfeeding is often presumed to be impossible in affected women, and guidance on lactation in this population is scarce.</p> Methods <p>We conducted a literature search to identify reports describing breastfeeding outcomes in women with hypopituitarism or panhypopituitarism and examined clinical, obstetric, and treatment-related factors (including prior pituitary surgery and radiation therapy) potentially associated with breastfeeding success.</p> Case study <p>We report the case of a 34-year-old pregnant woman with panhypopituitarism in Israel who established and maintained a sustained partial breastfeeding relationship following delivery. Lactation support included intranasal oxytocin administered before each breastfeed, use of a homemade nursing supplementer, galactagogues, and regular pumping. Breastfeeding was maintained for 6.5 months with infant formula supplementation.</p> Results of literature review <p>We identified reports of lactation outcomes in 69 parous women with pituitary hormone deficiencies, 20 of whom were reported to have breastfed. In an exploratory multivariable logistic regression analysis incorporating demographic, medical, and labor-related variables, prior radiation therapy appeared to be associated with a lower likelihood of breastfeeding.</p> Conclusions <p>This case and literature review suggest that breastfeeding may be possible in some women with panhypopituitarism, given individualized preparation and multidisciplinary support. The use of intranasal oxytocin in this context is hypothesis-generating and warrants further study. We propose a management checklist to assist clinicians in supporting individuals with panhypopituitarism who wish to breastfeed.</p> Clinical trial registration <p>Not applicable.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Breastfeeding in panhypopituitarism: a case report, review of the literature, and management checklist

  • Yael Derdikman Ofir,
  • Anne Eglash,
  • Kerstin Uvnäs Moberg,
  • Esther Tahover,
  • Irit Hochberg

摘要

Background

Panhypopituitarism is a rare endocrine disorder characterized by deficiency of multiple pituitary hormones. Because prolactin and oxytocin are essential for lactation, breastfeeding is often presumed to be impossible in affected women, and guidance on lactation in this population is scarce.

Methods

We conducted a literature search to identify reports describing breastfeeding outcomes in women with hypopituitarism or panhypopituitarism and examined clinical, obstetric, and treatment-related factors (including prior pituitary surgery and radiation therapy) potentially associated with breastfeeding success.

Case study

We report the case of a 34-year-old pregnant woman with panhypopituitarism in Israel who established and maintained a sustained partial breastfeeding relationship following delivery. Lactation support included intranasal oxytocin administered before each breastfeed, use of a homemade nursing supplementer, galactagogues, and regular pumping. Breastfeeding was maintained for 6.5 months with infant formula supplementation.

Results of literature review

We identified reports of lactation outcomes in 69 parous women with pituitary hormone deficiencies, 20 of whom were reported to have breastfed. In an exploratory multivariable logistic regression analysis incorporating demographic, medical, and labor-related variables, prior radiation therapy appeared to be associated with a lower likelihood of breastfeeding.

Conclusions

This case and literature review suggest that breastfeeding may be possible in some women with panhypopituitarism, given individualized preparation and multidisciplinary support. The use of intranasal oxytocin in this context is hypothesis-generating and warrants further study. We propose a management checklist to assist clinicians in supporting individuals with panhypopituitarism who wish to breastfeed.

Clinical trial registration

Not applicable.